Skip to main content

Table 2 shows the answers of patients regarding general willingness to participate in the preparation process and in the conduction of RCTs (2a) as well as the type of participation (2b)

From: Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients

  n total Fully agree
(1)
partially agree
(2)
neutral
(3)
partially disagree
(4)
fully disagree
(5)
No answer
a – general willingness to participate
Patients should participate in the
CDP of a clinical trial
30 67% 17% 17% 0% 0% 0%
Patients should participate in the
conduction of a clinical trial
30 57% 27% 7% 10% 0% 0%
The involvement of patients improves
the quality of clinical trials
30 50% 33% 13% 3% 0% 0%
I would participate in the CDP/conduction
of a clinical trial without financial compensation
30 53% 20% 20% 3% 0% 3%
A time expenditure of 10 h
per months would be feasible
30 23% 7% 7% 10% 50% 3%
time expenditure of 2 h
per months would be feasible
30 70% 13% 10% 0% 7% 0%
b – type of participation
Patients should be involved in definition of study endpoints 30 40% 17% 27% 7% 3% 7%
Patients should be involved in definition of inclusion/exclusion criteria 30 27% 17% 13% 23% 13% 7%
Patients should be involved in definition of
study specific procedures/examinations
30 17% 30% 40% 3% 3% 7%
Patients should visit meet regularly with the investigators to obtain updates 30 50% 37% 7% 3% 0% 3%